Advantage Alpha Capital Partners LP Omnicell, Inc Transaction History

Advantage Alpha Capital Partners LP

$419 Million
Q3 2024

A detailed history of Advantage Alpha Capital Partners LP transactions in Omnicell, Inc stock. As of the latest transaction made, Advantage Alpha Capital Partners LP holds 45,288 shares of OMCL stock, worth $2.02 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares

45,288

Previous 69,773 35.09%

Holding current value

$2.02 Million

Previous $1.89 Million 4.56%

% of portfolio

0.47%

Previous 0.43%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$25.61 - $45.43 $627,060 - $1.11 Million	-24,485 Reduced 35.09%	45,288 $1.97 Million
Q2 2024 Aug 13, 2024	SELL	$26.22 - $32.65 $1 Million - $1.25 Million	-38,181 Reduced 35.37%	69,773 $1.89 Million
Q1 2024 May 13, 2024	BUY	$26.15 - $37.33 $1.11 Million - $1.58 Million	42,429 Added 64.75%	107,954 $3.16 Million
Q4 2023 Feb 13, 2024	BUY	$29.24 - $45.81 $41,403 - $64,866	1,416 Added 2.21%	65,525 $2.47 Million
Q3 2023 Nov 14, 2023	BUY	$44.6 - $73.38 $601,029 - $988,868	13,476 Added 26.62%	64,109 $2.89 Million
Q2 2023 Aug 14, 2023	BUY	$57.88 - $75.94 $16,669 - $21,870	288 Added 0.57%	50,633 $3.73 Million
Q1 2023 May 12, 2023	SELL	$51.51 - $60.43 $522,053 - $612,458	-10,135 Reduced 16.76%	50,345 $2.95 Million
Q4 2022 Feb 14, 2023	SELL	$46.24 - $90.03 $2.42 Million - $4.72 Million	-52,407 Reduced 46.42%	60,480 $3.05 Million
Q3 2022 Nov 14, 2022	BUY	$84.23 - $117.38 $3.49 Million - $4.86 Million	41,395 Added 57.9%	112,887 $9.83 Million
Q2 2022 Aug 12, 2022	BUY	$105.64 - $129.11 $4.27 Million - $5.22 Million	40,437 Added 130.21%	71,492 $8.13 Million
Q1 2022 May 16, 2022	BUY	$120.68 - $180.51 $1.01 Million - $1.5 Million	8,335 Added 36.69%	31,055 $4.02 Million
Q4 2021 Feb 14, 2022	BUY	$153.26 - $183.62 $624,994 - $748,802	4,078 Added 21.88%	22,720 $4.1 Million
Q3 2021 Nov 15, 2021	BUY	$141.84 - $160.88 $45,246 - $51,320	319 Added 1.74%	18,642 $2.77 Million
Q2 2021 Aug 16, 2021	SELL	$129.91 - $151.45 $1.03 Million - $1.2 Million	-7,913 Reduced 30.16%	18,323 $2.78 Million
Q1 2021 May 13, 2021	BUY	$117.78 - $143.9 $462,286 - $564,807	3,925 Added 17.59%	26,236 $3.41 Million
Q4 2020 Feb 16, 2021	SELL	$73.85 - $120.02 $4.64 Million - $7.55 Million	-62,892 Reduced 73.81%	22,311 $2.68 Million
Q3 2020 Nov 16, 2020	BUY	$63.15 - $77.12 $2.26 Million - $2.76 Million	35,851 Added 72.64%	85,203 $6.36 Million
Q2 2020 Aug 13, 2020	BUY	$59.36 - $74.43 $401,214 - $503,072	6,759 Added 15.87%	49,352 $3.49 Million
Q1 2020 May 15, 2020	BUY	$55.41 - $90.19 $393,688 - $640,799	7,105 Added 20.02%	42,593 $2.79 Million
Q4 2019 Feb 14, 2020	BUY	$70.15 - $83.11 $2.49 Million - $2.95 Million	35,488 New	35,488 $2.9 Million

Others Institutions Holding OMCL

# of Institutions

276

Shares Held

44.3M

Call Options Held

224K

Put Options Held

35.7K

View Full List

About OMNICELL, Inc

Ticker OMCL
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 44,288,800
Market Cap $1.97B
Description
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensi...

More about OMCL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advantage Alpha Capital Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Advantage Alpha Capital Partners LP with notifications on news.

Account

Advantage Alpha Capital Partners LP Omnicell, Inc Transaction History